D. E. Shaw & Co., Inc. Alnylam Pharmaceuticals, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $5.46 Million - $9.41 Million	-38,100 Reduced 89.23%	4,600 $1.12 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $5.58 Million - $7.55 Million	38,100 Added 828.26%	42,700 $6.38 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $696,486 - $904,222	4,600 New	4,600 $880,000
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $2.07 Million - $2.72 Million	13,000 Added 108.33%	25,000 $4.24 Million
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $4.22 Million - $5.8 Million	-32,800 Reduced 73.21%	12,000 $2.03 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $1.58 Million - $2.38 Million	-15,200 Reduced 25.33%	44,800 $6.64 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $4.23 Million - $6.08 Million	45,400 Added 310.96%	60,000 $6.53 Million
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $894,120 - $1.49 Million	-12,000 Reduced 45.11%	14,600 $1.68 Million
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $545,930 - $676,214	-7,700 Reduced 22.45%	26,600 $2.14 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $92,204 - $129,906	1,400 Added 4.26%	34,300 $2.49 Million
Q1 2019 May 15, 2019	SELL	$72.76 - $93.45 $974,984 - $1.25 Million	-13,400 Reduced 28.94%	32,900 $3.08 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $382,287 - $538,813	-6,100 Reduced 11.64%	46,300 $3.38 Million
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $3.58 Million - $5.02 Million	40,900 Added 355.65%	52,400 $4.59 Million
Q2 2018 Aug 14, 2018	SELL	$88.31 - $107.8 $397,395 - $485,100	-4,500 Reduced 28.13%	11,500 $1.13 Million
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $266,616 - $341,642	2,300 Added 16.79%	16,000 $1.91 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $457,960 - $559,920	4,000 Added 41.24%	13,700 $1.74 Million
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $703,541 - $1.15 Million	9,700	9,700 $1.14 Million

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$3.93 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.01 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.27 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.25 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.18 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account